If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

HZNP Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.50%

Insider Buying (Last 12 Months): $49,669.15

Insider Selling (Last 12 Months): $67,962,666.51

Horizon Therapeutics Public Insider Trading History Chart

Horizon Therapeutics Public Share Price & Price History

^$109.13

▲ +0.61 (0.56%)

As of 03/27/2023 02:21 PM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

Horizon Therapeutics Public Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/17/2023	Andy Pasternak	EVP	Sell	27,129	$113.03	$3,066,390.87	56,338
1/13/2023	Aaron Cox	CFO	Sell	36,148	$113.17	$4,090,869.16	277
1/10/2023	Jeffrey W. Sherman	EVP	Sell	3,368	$113.05	$380,752.40	39,539
1/6/2023	Jeffrey W. Sherman	EVP	Sell	5,187	$113.29	$587,635.23	49,314
12/12/2022	Jeffrey W. Sherman	EVP	Sell	28,352	$111.45	$3,159,830.40	54,501
8/4/2022	Sean M Clayton	EVP	Buy	745	$66.67	$49,669.15	745
7/29/2022	Andy Pasternak	EVP	Sell	4,850	$82.57	$400,464.50	34,047
7/19/2022	Elizabeth H. Z. Thompson	EVP	Sell	90	$85.04	$7,653.60	12,886
7/7/2022	Elizabeth H. Z. Thompson	EVP	Sell	82	$85.01	$6,970.82	12,976
6/10/2022	Andy Pasternak	EVP	Sell	762	$85.36	$65,044.32	38,897
6/3/2022	Timothy P. Walbert	CEO	Sell	25,000	$92.34	$2,308,500.00	435,826
5/31/2022	Timothy P. Walbert	CEO	Sell	25,000	$92.48	$2,312,000.00	435,549
5/20/2022	Timothy P. Walbert	CEO	Sell	25,000	$90.00	$2,250,000.00	460,549
5/11/2022	Timothy P. Walbert	CEO	Sell	17,600	$90.00	$1,584,000.00	460,549
5/6/2022	Timothy P. Walbert	CEO	Sell	7,400	$90.86	$672,364.00	460,549
4/22/2022	Timothy P. Walbert	CEO	Sell	25,000	$106.59	$2,664,750.00	485,549
4/20/2022	Paul W Hoelscher	CFO	Sell	50,000	$114.71	$5,735,500.00	1,049
4/12/2022	Michael A Desjardin	EVP	Sell	20,214	$113.12	$2,286,607.68	82,346
4/8/2022	Timothy P. Walbert	CEO	Sell	25,000	$112.38	$2,809,500.00	485,549
4/6/2022	Jeffrey W. Sherman	EVP	Sell	42,009	$110.02	$4,621,830.18	10,629
4/6/2022	Paul W Hoelscher	CFO	Sell	215,335	$110.01	$23,689,003.35	1,049
3/30/2022	Timothy P. Walbert	CEO	Sell	50,000	$105.26	$5,263,000.00
3/25/2022	Paul W Hoelscher	CFO	Sell	663	$110.00	$72,930.00
3/25/2022	Timothy P. Walbert	CEO	Sell	25,000	$109.37	$2,734,250.00
3/23/2022	Paul W Hoelscher	CFO	Sell	26,090	$110.00	$2,869,900.00
3/11/2022	Timothy P. Walbert	CEO	Sell	25,000	$100.93	$2,523,250.00
2/18/2022	Andy Pasternak	EVP	Sell	1,313	$94.82	$124,498.66
2/11/2022	Timothy P. Walbert	CEO	Sell	25,000	$97.41	$2,435,250.00
1/31/2022	Timothy P. Walbert	CEO	Sell	100,000	$91.85	$9,185,000.00
1/28/2022	Timothy P. Walbert	CEO	Sell	25,000	$90.00	$2,250,000.00
1/14/2022	Timothy P. Walbert	CEO	Sell	25,000	$90.02	$2,250,500.00
1/6/2022	Andy Pasternak	EVP	Sell	7,987	$99.57	$795,265.59
12/28/2021	Paul W Hoelscher	CFO	Sell	8,575	$110.00	$943,250.00
12/7/2021	Andy Pasternak	EVP	Sell	1,525	$100.00	$152,500.00
11/30/2021	Timothy P. Walbert	CEO	Sell	50,000	$102.40	$5,120,000.00
11/4/2021	Andy Pasternak	EVP	Sell	30,168	$113.04	$3,410,190.72
11/1/2021	Timothy P. Walbert	CEO	Sell	25,000	$118.49	$2,962,250.00
9/30/2021	Timothy P. Walbert	CEO	Sell	50,000	$110.30	$5,515,000.00
9/21/2021	Jeffrey W. Sherman	EVP	Sell	46,271	$110.00	$5,089,810.00
9/17/2021	Brian K. Beeler	EVP	Sell	28,143	$107.91	$3,036,911.13	62,775
9/9/2021	Andy Pasternak	EVP	Sell	23,250	$107.84	$2,507,280.00	46,604
8/5/2021	Elizabeth H. Z. Thompson	EVP	Sell	7,542	$106.34	$802,016.28	14,187
7/30/2021	Timothy P. Walbert	CEO	Sell	25,000	$101.74	$2,543,500.00
7/22/2021	Michael G. Grey	Director	Sell	5,000	$100.04	$500,200.00
7/8/2021	Barry Moze	EVP	Sell	35,076	$92.54	$3,245,933.04
5/14/2021	Paul W. Hoelscher	CFO	Sell	102,925	$90.01	$9,264,279.25	2,362
5/10/2021	William F. Daniel	Director	Sell	20,000	$86.56	$1,731,200.00	20,000
4/30/2021	Timothy P. Walbert	CEO	Sell	25,000	$94.98	$2,374,500.00	920,710
4/12/2021	Barry Moze	EVP	Sell	65,613	$88.96	$5,836,932.48	120,025
4/12/2021	Michael G. Grey	Director	Sell	15,000	$90.28	$1,354,200.00	15,000
4/1/2021	Geoffrey M. Curtis	EVP	Sell	70,739	$93.51	$6,614,803.89	103,414
3/30/2021	Daniel A. Camardo	EVP	Sell	12,900	$85.50	$1,102,950.00	43,997
2/26/2021	Michael A Desjardin	EVP	Sell	1,099	$91.83	$100,921.17	92,504
2/24/2021	Michael A Desjardin	EVP	Sell	15,944	$92.48	$1,474,501.12	92,504
2/22/2021	Vikram Karnani	EVP	Sell	8,358	$87.19	$728,734.02	104,810
2/11/2021	Michael A Desjardin	EVP	Sell	10,786	$90.00	$970,740.00	101,200
2/2/2021	Michael A Desjardin	EVP	Sell	4,530	$85.00	$385,050.00	111,986
1/22/2021	Timothy P. Walbert	CEO	Sell	11,323	$76.47	$865,869.81	966,889
1/22/2021	Vikram Karnani	EVP	Sell	2,731	$76.81	$209,768.11	116,333
1/15/2021	Timothy P. Walbert	CEO	Sell	211,204	$77.89	$16,450,679.56	1,076,362
1/6/2021	Irina Konstantinovsky	EVP	Sell	26,844	$74.76	$2,006,857.44	112,717
12/14/2020	Miles W Mchugh	SVP	Sell	1,856	$80.00	$148,480.00	19,741
12/10/2020	Michael A Desjardin	EVP	Sell	5,909	$69.64	$411,502.76	63,392
12/7/2020	Jeffrey W. Sherman	EVP	Sell	63,078	$70.94	$4,474,753.32	28,015
11/12/2020	Miles W Mchugh	SVP	Sell	12,124	$75.48	$915,119.52	21,597
11/6/2020	Daniel A. Camardo	EVP	Sell	3,500	$76.76	$268,660.00	30,829
11/5/2020	Jeff Kent	Insider	Sell	47,944	$78.94	$3,784,699.36	71,799
9/16/2020	Irina Konstantinovsky	EVP	Sell	8,919	$78.88	$703,530.72	36,022
8/24/2020	Paul W. Hoelscher	CFO	Sell	29,576	$75.76	$2,240,677.76
8/6/2020	Timothy P. Walbert	CEO	Sell	110,000	$72.54	$7,979,400.00
8/5/2020	Michael G. Grey	Director	Sell	1,755	$73.35	$128,729.25	1,755
7/22/2020	Michael G. Grey	Director	Sell	1,755	$60.00	$105,300.00	1,755
7/6/2020	Jeffrey W. Sherman	EVP	Sell	9,100	$57.50	$523,250.00
7/1/2020	Barry Moze	EVP	Sell	23,158	$54.64	$1,265,353.12	145,242
6/25/2020	Michael G. Grey	Director	Sell	1,755	$55.00	$96,525.00	1,755
6/10/2020	Jeff Kent	Insider	Sell	2,785	$48.05	$133,819.25	65,994
6/1/2020	Jeff Kent	Insider	Sell	57,215	$49.94	$2,857,317.10
6/1/2020	Vikram Karnani	EVP	Sell	2,369	$50.23	$118,994.87
5/22/2020	Michael G. Grey	Director	Sell	10,530	$48.77	$513,548.10	10,530
5/11/2020	Jeffrey W. Sherman	EVP	Sell	33,479	$45.00	$1,506,555.00	47,445
5/11/2020	Miles W Mchugh	SVP	Sell	49,114	$44.22	$2,171,821.08	125,296
5/8/2020	Miles W Mchugh	SVP	Sell	45,366	$43.51	$1,973,874.66	125,296
5/6/2020	Brian K Beeler	EVP	Sell	48,000	$40.80	$1,958,400.00	37,206
5/5/2020	Miles W Mchugh	SVP	Sell	5,007	$37.00	$185,259.00	132,640
5/5/2020	Paul W Hoelscher	CFO	Sell	104,994	$38.00	$3,989,772.00
4/29/2020	Brian K Beeler	EVP	Sell	15,880	$35.02	$556,117.60	85,206
4/20/2020	Irina Konstantinovsky	EVP	Sell	19,886	$34.13	$678,709.18	35,389
4/16/2020	Brian K Beeler	EVP	Sell	9,000	$32.51	$292,590.00	101,086
4/6/2020	Brian K Beeler	EVP	Sell	2,370	$32.50	$77,025.00	110,383
3/30/2020	Barry Moze	EVP	Sell	2,106	$28.18	$59,347.08	168,397

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

SEC Filings (Institutional Ownership Changes) for Horizon Therapeutics Public (NASDAQ:HZNP)

91.01% of Horizon Therapeutics Public stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Horizon Therapeutics Public Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/13/2023	Crystalline Management Inc.	45,000	$5.12M	2.6%	N/A	0.020%
3/10/2023	Mather Group LLC.	2,759	$0.31M	0.0%	N/A	0.001%
3/10/2023	Victory Capital Management Inc.	161,430	$18.37M	0.0%	+6.9%	0.071%
3/6/2023	Rockefeller Capital Management L.P.	102,104	$11.62M	0.1%	+4,314.4%	0.045%
2/28/2023	Voya Investment Management LLC	411,424	$46.82M	0.1%	-40.3%	0.182%
2/21/2023	Macquarie Group Ltd.	88,514	$10.07M	0.0%	-95.1%	0.039%
2/21/2023	Wallace Advisory Group LLC	2,813	$0.32M	0.3%	N/A	0.001%
2/21/2023	Northwestern Mutual Wealth Management Co.	433	$49K	0.0%	+209.3%	0.000%
2/17/2023	Truist Financial Corp	68,560	$7.80M	0.0%	-20.6%	0.030%
2/16/2023	Alliancebernstein L.P.	466,707	$53.11M	0.0%	-68.8%	0.206%
2/16/2023	United Capital Financial Advisers LLC	6,169	$0.70M	0.0%	-9.1%	0.003%
2/16/2023	Chartwell Investment Partners LLC	23,052	$2.62M	0.1%	-79.6%	0.010%
2/15/2023	Public Employees Retirement System of Ohio	116,417	$13.25M	0.1%	-0.9%	0.051%
2/15/2023	CI Private Wealth LLC	12,131	$1.38M	0.0%	N/A	0.005%
2/15/2023	Utah Retirement Systems	39,300	$4.47M	0.1%	-2.2%	0.017%
2/15/2023	Nekton Capital Ltd.	270,915	$30.83M	7.0%	N/A	0.120%
2/15/2023	Captrust Financial Advisors	5,160	$0.59M	0.0%	+7.1%	0.002%
2/15/2023	Kiwi Wealth Investments Limited Partnership	1,948	$0.22M	0.0%	-97.4%	0.001%
2/15/2023	Employees Retirement System of Texas	79,722	$9.07M	0.1%	-30.2%	0.035%
2/15/2023	PFS Investments Inc.	19,321	$2.20M	0.0%	-2.1%	0.009%
2/15/2023	Gamco Investors INC. ET AL	23,350	$2.66M	0.0%	N/A	0.010%
2/15/2023	Cerity Partners LLC	7,769	$0.88M	0.0%	+32.5%	0.003%
2/15/2023	Virtu Financial LLC	47,458	$5.40M	0.7%	N/A	0.021%
2/15/2023	Vestcor Inc	60,386	$6.87M	0.3%	+1,074.1%	0.027%
2/15/2023	Toroso Investments LLC	9,820	$1.12M	0.0%	+140.7%	0.004%
2/15/2023	Silverarc Capital Management LLC	23,054	$2.62M	0.8%	+127.6%	0.010%
2/15/2023	State of Wisconsin Investment Board	173,709	$19.77M	0.1%	-56.6%	0.077%
2/15/2023	Sand Grove Capital Management LLP	339,649	$38.65M	3.7%	N/A	0.150%
2/15/2023	T. Rowe Price Investment Management Inc.	4,050,259	$460.92M	0.4%	N/A	1.787%
2/15/2023	Legal & General Group Plc	31,776	$3.62M	0.0%	+19.3%	0.014%
2/15/2023	Lombard Odier Asset Management Switzerland SA	74,525	$8.48M	0.7%	N/A	0.033%
2/15/2023	Lombard Odier Asset Management USA Corp	16,500	$1.88M	0.0%	N/A	0.007%
2/15/2023	Morgan Stanley	1,501,384	$170.86M	0.0%	-11.9%	0.663%
2/15/2023	Man Group plc	651,030	$74.09M	0.3%	+77.0%	0.287%
2/15/2023	Mariner LLC	79,339	$9.03M	0.0%	-13.4%	0.035%
2/15/2023	Nissay Asset Management Corp Japan ADV	23,731	$2.70M	0.0%	-0.5%	0.010%
2/15/2023	Norges Bank	2,194,888	$249.78M	0.1%	N/A	0.969%
2/15/2023	E Fund Management Co. Ltd.	4,346	$0.50M	0.0%	-39.7%	0.002%
2/15/2023	Eagle Asset Management Inc.	823,124	$93.42M	0.6%	-10.8%	0.363%
2/15/2023	Eqis Capital Management Inc.	7,121	$0.81M	0.1%	+17.9%	0.003%
2/15/2023	Eversept Partners LP	1,064,446	$121.13M	11.2%	-16.2%	0.470%
2/15/2023	Fjarde AP Fonden Fourth Swedish National Pension Fund	90,884	$10.34M	0.1%	-1.7%	0.040%
2/15/2023	First Light Asset Management LLC	137,077	$15.60M	1.4%	N/A	0.060%
2/15/2023	Flow State Investments L.P.	20,000	$2.28M	2.0%	N/A	0.009%
2/15/2023	Glazer Capital LLC	360,496	$41.02M	1.1%	N/A	0.159%
2/15/2023	Angelo Gordon & CO. L.P.	20,000	$2.28M	0.4%	N/A	0.009%
2/15/2023	AQR Arbitrage LLC	525,530	$59.70M	1.5%	N/A	0.232%
2/15/2023	AQR Capital Management LLC	290,795	$33.03M	0.1%	-50.2%	0.128%
2/15/2023	Arena Investors LP	25,058	$2.85M	2.6%	N/A	0.011%
2/15/2023	Avoro Capital Advisors LLC	7,000,000	$796.60M	11.9%	+36.6%	3.089%
2/15/2023	Paulson & CO. Inc.	1,500,000	$170.70M	15.4%	-75.4%	0.662%
2/15/2023	Caisse DE Depot ET Placement DU Quebec	76,777	$8.74M	0.0%	-92.0%	0.034%
2/15/2023	ICA Group Wealth Management LLC	958	$0.11M	0.0%	N/A	0.000%
2/14/2023	First Trust Capital Management L.P.	375,593	$42.74M	2.3%	N/A	0.166%
2/14/2023	Baader Bank Aktiengesellschaft	9,000	$1.02M	0.0%	N/A	0.004%
2/14/2023	Vident Investment Advisory LLC	103,090	$11.73M	0.4%	+26.1%	0.045%
2/14/2023	Alyeska Investment Group L.P.	3,113	$0.35M	0.0%	N/A	0.001%
2/14/2023	Price T Rowe Associates Inc. MD	635,055	$72.27M	0.0%	-19.6%	0.280%
2/14/2023	Moore Capital Management LP	62,000	$7.06M	0.2%	N/A	0.027%
2/14/2023	Meiji Yasuda Asset Management Co Ltd.	20,340	$2.32M	0.1%	-0.9%	0.009%
2/14/2023	Cetera Advisor Networks LLC	8,978	$1.02M	0.0%	+84.7%	0.004%
2/14/2023	Cetera Investment Advisers	3,588	$0.41M	0.0%	N/A	0.002%
2/14/2023	Cetera Advisors LLC	1,956	$0.22M	0.0%	N/A	0.001%
2/14/2023	Amundi	284,349	$32.17M	0.0%	+2.8%	0.125%
2/14/2023	Marshall Wace LLP	467,291	$53.18M	0.1%	-81.4%	0.206%
2/14/2023	Two Sigma Advisers LP	158,300	$18.02M	0.1%	-58.0%	0.070%
2/14/2023	Alpine Global Management LLC	20,000	$2.28M	0.8%	N/A	0.009%
2/14/2023	Two Sigma Investments LP	13,900	$1.58M	0.0%	-95.9%	0.006%
2/14/2023	Arrowstreet Capital Limited Partnership	41,280	$4.70M	0.0%	N/A	0.018%
2/14/2023	Vazirani Asset Management LLC	37,749	$4.30M	7.3%	N/A	0.017%
2/14/2023	Allstate Investment Management Co.	6,282	$0.72M	0.0%	N/A	0.003%
2/14/2023	Engineers Gate Manager LP	6,888	$0.78M	0.0%	-43.9%	0.003%
2/14/2023	Qtron Investments LLC	2,218	$0.25M	0.1%	N/A	0.001%
2/14/2023	Soros Fund Management LLC	2,858,501	$325.30M	4.5%	N/A	1.261%
2/14/2023	Townsquare Capital LLC	49,095	$5.59M	0.1%	+6.8%	0.022%
2/13/2023	Advisors Asset Management Inc.	4,773	$0.54M	0.0%	+47.1%	0.002%
2/13/2023	DLD Asset Management LP	160,000	$18.21M	1.5%	N/A	0.071%
2/13/2023	First Republic Investment Management Inc.	12,084	$1.38M	0.0%	+10.1%	0.005%
2/13/2023	Charles Schwab Investment Management Inc.	909,597	$103.51M	0.0%	-3.1%	0.401%
2/13/2023	Deutsche Bank AG	2,061,143	$234.56M	0.1%	+6.3%	0.910%
2/13/2023	Steward Financial Group LLC	532	$60K	0.0%	N/A	0.000%
2/13/2023	Northeast Financial Consultants Inc	2,068	$0.24M	0.0%	N/A	0.001%
2/13/2023	GABELLI & Co INVESTMENT ADVISERS INC.	147,700	$16.81M	3.6%	N/A	0.065%
2/13/2023	Gabelli Funds LLC	222,000	$25.26M	0.2%	N/A	0.098%
2/13/2023	Gamco Investors INC. ET AL	23,350	$2.66M	0.0%	N/A	0.010%
2/13/2023	CIBC Asset Management Inc	7,579	$0.86M	0.0%	-26.7%	0.003%
2/13/2023	Panagora Asset Management Inc.	10,337	$1.18M	0.0%	-6.8%	0.005%
2/13/2023	Integrated Wealth Concepts LLC	3,170	$0.36M	0.0%	-16.9%	0.001%
2/13/2023	Boulder Hill Capital Management LP	13,000	$1.48M	1.2%	N/A	0.006%
2/13/2023	Twin Tree Management LP	183,077	$20.83M	0.0%	N/A	0.081%
2/13/2023	Dark Forest Capital Management LP	24,979	$2.84M	0.7%	N/A	0.011%
2/13/2023	Renaissance Technologies LLC	1,675,049	$190.62M	0.3%	+7.3%	0.739%
2/13/2023	Picton Mahoney Asset Management	270,000	$30.73M	1.4%	N/A	0.119%
2/13/2023	Credit Suisse AG	362,586	$41.26M	0.0%	+22.3%	0.160%
2/13/2023	CTC Capital Management LLC	3,405	$0.39M	0.5%	N/A	0.002%
2/13/2023	Neuberger Berman Group LLC	700,166	$79.68M	0.1%	-53.9%	0.309%
2/13/2023	Geode Capital Management LLC	3,073,801	$349.39M	0.0%	+1.8%	1.356%
2/13/2023	Cigna Investments Inc. New	2,452	$0.28M	0.1%	N/A	0.001%
2/13/2023	American Century Companies Inc.	383,941	$43.69M	0.0%	-73.3%	0.169%
2/13/2023	PSquared Asset Management AG	1,603,700	$181.73M	52.2%	N/A	0.708%

Data available starting January 2016

Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland.

Today's Range

Now: $109.13

$108.63

$109.24

50 Day Range

MA: $110.24

$107.32

$113.24

52 Week Range

Now: $109.13

$57.84

$117.49

Volume

799,456 shs

Average Volume

2,467,591 shs

Market Capitalization

$24.93 billion

P/E Ratio

48.94

Dividend Yield

N/A

Beta

1.15

Who are the company insiders with the largest holdings of Horizon Therapeutics Public?: Horizon Therapeutics Public's top insider shareholders include:
Timothy P Walbert (CEO)
Barry Moze (EVP)
Geoffrey M Curtis (EVP)
Michael A Desjardin (EVP)
Brian K Beeler (EVP)
Andy Pasternak (EVP)
Jeffrey W Sherman (EVP)
Daniel A Camardo (EVP)
William F Daniel (Director)
Michael G Grey (Director)
Elizabeth HZ Thompson (EVP)
Paul W Hoelscher (CFO)
Paul W Hoelscher (CFO)
Sean M Clayton (EVP)
Aaron Cox (CFO)
Learn More about top insider investors at Horizon Therapeutics Public.
Who are the major institutional investors of Horizon Therapeutics Public?: Horizon Therapeutics Public's top institutional investors include:
Avoro Capital Advisors LLC — 3.09%
T. Rowe Price Investment Management Inc. — 1.79%
Geode Capital Management LLC — 1.36%
Soros Fund Management LLC — 1.26%
Norges Bank — 0.97%
Deutsche Bank AG — 0.91%
Learn More about top institutional investors of Horizon Therapeutics Public stock.
Which major investors are selling Horizon Therapeutics Public stock?: During the last quarter, HZNP stock was sold by these institutional investors:
Paulson & CO. Inc.
Marshall Wace LLP
William Blair Investment Management LLC
Macquarie Group Ltd.
Bank of Nova Scotia
Jennison Associates LLC
American Century Companies Inc.
Alliancebernstein L.P.
Within the last year, company insiders that have sold Horizon Therapeutics Public company stock include:
Timothy P Walbert (CEO)
Barry Moze (EVP)
Geoffrey M Curtis (EVP)
Michael A Desjardin (EVP)
Brian K Beeler (EVP)
Andy Pasternak (EVP)
Jeffrey W Sherman (EVP)
Learn More investors selling Horizon Therapeutics Public stock.
Which major investors are buying Horizon Therapeutics Public stock?: During the last quarter, HZNP stock was acquired by institutional investors including:
T. Rowe Price Investment Management Inc.
Soros Fund Management LLC
Norges Bank
Avoro Capital Advisors LLC
PSquared Asset Management AG
Alpine Associates Management Inc.
Susquehanna International Group LLP
Maven Securities LTD

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

HZNP Insider Trading

Horizon Therapeutics Public Insider Trading History Chart

Horizon Therapeutics Public Share Price & Price History

Horizon Therapeutics Public Insider Trading History

SEC Filings (Institutional Ownership Changes) for Horizon Therapeutics Public (NASDAQ:HZNP)

Institutional Buying and Selling by Quarter

Horizon Therapeutics Public Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Horizon Therapeutics Public?

Who are the major institutional investors of Horizon Therapeutics Public?

Which major investors are selling Horizon Therapeutics Public stock?

Which major investors are buying Horizon Therapeutics Public stock?